Nomination Committee for Senzime Annual General Meeting 2026

November 3, 2025 9:00 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - A Nomination Committee consisting of shareholder representatives has been established for Senzime AB (publ.) in accordance with the principles adopted by the annual general meeting held on May 19, 2025.Members of the Nomination Committee are:Adam Dahlberg, representing the Crafoord family and Crafoord FoundationGabriel Urwitz, representing Segulah AB, Segulah Venture and Segulah Medical AccelerationFredrik...

Read more

"Prejuvenation" Surge: Dr. Shervin Naderi Reveals How Millennials and Gen X Are Delaying Aging - Without Surgery

November 3, 2025 9:00 AM

A new beauty movement is changing the face of aesthetic medicine-literally. Called prejuvenation, it's the proactive approach to skincare and non-surgical treatments that aims to delay the visible signs of aging before they start.At the forefront of this trend is Dr. Shervin Naderi, board-certified facial plastic surgeon and founder of The Naderi Center for Plastic Surgery and Dermatology. Dr. Naderi explains, "The art of aesthetic medicine is...

Read more

Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules

November 3, 2025 9:00 AM

Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB:CYTOF), a company dedicated to developing and commercializing nucleic acid delivery technology for targets beyond the liver, today announced that its nanoparticle-based delivery platform was successfully tested to deliver DNA molecules. In vitro experiments demonstrated efficient transfection of cells and reliable expression of the encoded proteins. Altamira will start offering its...

Read more

Tenon Medical, Inc. Announces Timing of Third Quarter 2025 Financial Results

November 3, 2025 8:30 AM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced plans to release financial results for the third quarter 2025 ended September 30, 2025 after market close on Thursday, November 13, 2025. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The...

Read more

NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd

November 3, 2025 8:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting today, Monday, November 3rd, at 09:45am ET at the Spartan Capital Investor Conference 2025 in New York City.Event Information:EventNanoViricides Presentation at the Spartan Capital Investor Conference - 2025, New York, NYTrack2DateMonday,...

Read more

Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System

November 3, 2025 8:30 AM

Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology, today announced the successful validation of its Pivot controller line, a critical milestone in preparing for the commercial launch of its Pivot patch pump targeted for Q1 2026. The Pivot controller line validation further demonstrates manufacturing readiness for high-volume production, positioning Modular Medical to meet...

Read more

Hoggan Scientific Extends Free Warranty Coverage From One Year to Three Years to Thank Customers

November 3, 2025 8:00 AM

To show Hoggan Scientific's ongoing commitment to customer satisfaction and product excellence, they are announcing a major enhancement to its warranty policy. Effective immediately, all new devices will be covered by a three-year warranty, up from the previous one-year coverage period, at no cost to customers. This milestone reflects not only Hoggan Scientifc's dedication to standing behind these products but also their pride in maintaining...

Read more

Flash Survey: Hospital IT Ops Leaders Name 2026 Must-Dos Across Tight, Flat, and Growth Budgets

November 3, 2025 8:00 AM

Black Book™ today released results from a flash survey of 139 U.S. hospital IT operations leaders (directors and VPs reporting into the C-suite). Respondents outlined a pragmatic 2026 playbook: get patient identity right, formalize change management, and ship on a predictable, secure release cadence-sequenced to each organization's budget and risk.Why this survey. Black Book polled hands-on IT operations leaders: the directors and VPs who manage...

Read more

Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma

November 3, 2025 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the Company's investigational mRNA-based T-cell engager (TCE) for participants with relapsed or refractory multiple myeloma (RRMM). The first dose was administered at SCRI Oncology Partners in Nashville, Tennessee, in collaboration with Sarah Cannon Research Institute (SCRI).mRNA-2808 is an investigational, multiplexed therapy...

Read more

100 Miles to Healing: Tampa Athlete Runs Across Bay to Celebrate Plant Medicine Transformation

November 3, 2025 6:00 AM

When endurance athlete John Borden launches into his 100-mile Tampa 100 run this November, he won't just be racing for a finish time - he will be running toward an entirely new identity.Borden, who struggled for years with burnout, chronic stress, and emotional collapse post-career, credits plant medicine, psilocybin-assisted integration, somatic training, and therapeutic lifestyle design for rebuilding his body, nervous system, and purpose. His...

Read more

Ascelia Pharma Announces Management Changes to Support Future Growth

November 3, 2025 5:15 AM

Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (ticker:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced changes to its executive leadership team. These changes are designed to strengthen the company's operational capabilities and position it for its next phase of growth.Ascelia Pharma has recruited Anton Hansson as Chief Financial Officer (CFO) who will join the company around late...

Read more

iZafe Group's quarterly report Q3, July-September 2025

November 3, 2025 2:50 AM

iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) today, November 3, presents its report for the third quarter.Summary of financial developmentTotal net revenue for the quarter amounted to 1,102 TSEK (2,031) and consisted entirely of recurring license revenues, with no hardware sales during the period. This stands in clear contrast to the same quarter last year, when revenues were largely derived from hardware sales. The development...

Read more

IQ Blast Pro Reviews (SAFETY REPORT) Doctors Reveal the Truth About Its Ingredients, Results & Complaints

November 2, 2025 12:15 PM

Across the U.S., neurologists are raising alarms about the silent rise of "neural fatigue", a modern epidemic linked to memory lapses, focus problems, and cognitive burnout. In 2025, one supplement called IQ Blast Pro has become the focus of both clinical curiosity and consumer demand. Positioned as a Doctor-Formulated, Stimulant-Free Cognitive Support Formula (Verified), IQ Blast Pro claims to strengthen the brain-blood barrier, what...

Read more

Audifort Reviews 2025 (SAFETY REPORT) Doctors Reveal the Real Science Behind This Hearing & Tinnitus Supplement

November 2, 2025 10:15 AM

If you've been living with constant ringing, muffled sounds, or the creeping fear of hearing decline, you already know how isolating it can feel. For years, the standard advice hasn't changed: hearing aids, white noise, or "learn to live with it." But in 2025, a new formula called Audifort is changing that conversation. Backed By Audiology Experts And Early Clinical Data (Verified), Audifort has become one of the most discussed natural hearing...

Read more

Women Leading the Psychedelic Renaissance: Female Voices Take Center Stage at Cannadelic Global

November 1, 2025 10:36 PM

Cannadelic Global Summit returns to St. Petersburg on November 9, 2025, and this year's speaker slate marks a historic shift: women will command the stage with some of the most pioneering, emotionally evocative and scientifically advanced talks of the entire conference.From erotic neurobiology to trauma regression, cannabinoid intimacy, athletic rebirth, and prosperity consciousness - the future of psychedelic medicine is being rewritten by...

Read more

Yu Sleep Reviews (SAFETY REPORT) Consumer Complaints, Ingredients Breakdown & Real Results Revealed 2025

November 1, 2025 3:20 PM

Sleep deprivation has quietly become one of the most pervasive public health issues of the modern era, impacting everything from emotional regulation to immune defense. Yet while millions turn to over-the-counter melatonin or sedatives for short-term relief, doctors now warn that these quick fixes often disrupt the body's circadian rhythm and create long-term dependency. Enter the Official Yu Sleep, a nano-enhanced, melatonin-free supplement...

Read more

ProstaVive Reviews (SAFETY REPORT) Consumer Complaints, Ingredients, and What Doctors Reveal About Side Effects in 2025

October 31, 2025 7:45 PM

As men cross into their 40s and 50s, the persistent interruptions of nighttime trips to the bathroom and the frustration of weakened urinary flow become far too common. With the aging prostate affecting millions of men, the launch of the supplement ProstaVive Powder arrives at a critical moment, offering a plant-based approach to prostate wellness that claims to bypass pharmaceuticals and their side-effects.But before you commit to this...

Read more

New Study Highlights Better Healing Outcomes for Pressure Ulcers With Advanced Wound Care Products 

October 31, 2025 7:00 PM

Venture Medical congratulates Open Wound Research on the publication of a new peer-reviewed study showing that patients with pressure ulcers treated with advanced wound care products healed significantly faster than those receiving standard care alone.The study, titled "Real-world evaluation of cellular, acellular, and matrix-like products for pressure ulcers in the post-acute setting," published in the International Journal of Tissue Repair,...

Read more

Onco-Innovations Provides Shareholder Update Following Cboe Canada Investor Spotlight

October 31, 2025 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide a corporate update outlining its strategic objectives for the upcoming year. The update follows Onco-Innovations' CEO Thomas O'Shaughnessy's recent appearance on Cboe Canada's Investor Spotlight (October 22, 2025), where he discussed Onco's mission to enhance cancer treatment technologies through innovation, AI-driven...

Read more

Recognizing Excellence in Respiratory Care and Education AARC Awards 2026-2027 Apex Designations

October 31, 2025 2:00 PM

The American Association for Respiratory Care (AARC) is proud to recognize 22 organizations for their exemplary demonstration of best practices in respiratory care and education as the 2026-2027 Apex Designation recipients. These organizations are part of an elite, worldwide group of respiratory care departments and educational programs that have met the stringent quality, clinical practice, or educational program criteria for the...

Read more